SAN FRANCISCO (MarketWatch) -- Biotechnology and drug stocks closed lower Wednesday, with Abbott Laboratories losing ground on a 19% decline in first-quarter profit, but MedImmune shares gained on speculation of an acquisition announcement by early next week.>>> Discuss This Story
